COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

URN to cite this document:: urn:nbn:de:bvb:355-epub-556412
DOI to cite this document:: 10.5283/epub.55641

Rüthrich, Maria Madeleine ; Giessen-Jung, C. ; Borgmann, S. ; Classen, A. Y. ; Dolff, S. ; Grüner, B. ; Hanses, F.

; Isberner, N. ; Köhler, P. ; Lanznaster, J. ; Merle, U. ; Nadalin, S. ; Piepel, C. ; Schneider, J. ; Schons, M. ; Strauss, R. ; Tometten, L. ; Vehreschild, J. J. ; von Lilienfeld-Toal, M. ; Beutel, G. ; Wille, K.

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 29 Feb 2024 12:10

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk. Patients and methods We retrospectively analyzed a cohort of 435 cancer ...